SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
BioSphere Medical, Inc. Submits Investigational Device Exemption to FDA for QuadraSphere(R) Microspheres for Use with Doxorubicin for the Treatment of Primary Liver Cancer